Cervical Cancer Diagnostics Forecast Report 2025 – Designed for Product & Growth Teams


 Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.

What is the current market size of the cervical cancer diagnostics industry, and what growth rate is it expected to achieve?
The cervical cancer diagnostics market size has grown strongly in recent years. It will grow from $9.27 billion in 2024 to $9.85 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increased awareness and screening programs, hpv vaccination, technological advancements, aging population.

The cervical cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $12.5 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing hpv-related cancers, emerging markets, molecular testing advances, telemedicine and remote screening. Major trends in the forecast period include hpv testing, liquid-based cytology, automation and digital pathology, screen-and-treat programs.

Download Your Free Sample PDF:
Cervical Cancer Diagnostics Market Report 2025

What are the major drivers contributing to the growth of the cervical cancer diagnostics market?
The rising adoption of cervical cancer diagnostic tests for the early detection of cervical cancer is expected to drive the market for cervical cancer diagnostics. Increasing awareness among women about cervical cancer along with the emphasis by worldwide cancer organizations and governments on early testing for detecting cervical cancer and preventing it contributes to the growth of the market. For instance, in July 2024, according to the Centers for Disease Control and Prevention, a US-based government agency in 2021, the United States reported 12,536 new cases of cervical cancer, while in 2022, the disease resulted in 4,051 fatalities among women. The rising adoption of cervical cancer diagnostic tests and emphasis on early diagnosis propels the growth of the cervical cancer diagnostics market.

What are the major market segments driving the growth of the cervical cancer diagnostics industry?
The cervical cancer diagnostics market covered in this report is segmented –

1) By Diagnostic Test: Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Other Diagnostic Tests
2) By Age Group: Below 21, Age between 21 to 29, Age between 30 to 65, Above 65
3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Diagnostic Centers

Subsegments:
1) By Pap Smear Test: Conventional Pap Smear, Liquid-Based Pap Smear
2) By HPV Test: DNA-Based HPV Test, RNA-Based HPV Test, Hybrid Capture HPV Test, Other HPV Tests
3) By Colposcopy: Standard Colposcopy, Digital Colposcopy, Optical Colposcopy
4) By Biopsy And Endocervical Curettage: Punch Biopsy, Endocervical Curettage (ECC), Cone Biopsy, Colposcopic Biopsy
5) By Other Diagnostic Tests: Visual Inspection With Acetic Acid (VIA), Cervical Cytology Testing, Blood Tests, Other Specialty Tests

View The Full Market Report:
Cervical Cancer Diagnostics Market Report 2025

What are the key trends shaping the cervical cancer diagnostics market in the forecast period?
Major companies operating in the cervical cancer diagnostics market are focusing on developing technologically innovative solutions, such as HPV self-collection solutions for cervical cancer, to increase accessibility to screening and enhance early detection rates. The HPV self-collection solution for cervical cancer refers to a method that allows individuals to collect their own samples for testing human papillomavirus (HPV), which is a major cause of cervical cancer. For instance, in May 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, received FDA approval for its HPV self-collection solution, a significant advancement in cervical cancer screening that enhances accessibility for individuals, particularly those in underserved populations. This innovative method allows women to privately collect vaginal samples for analysis using Roche's Cobas molecular HPV test, supporting the World Health Organization's goal of eliminating cervical cancer by 2030. The approval follows the successful IMPACT trial, which demonstrated the solution's effectiveness across diverse demographics.

Who are the key market players contributing to the growth of the cervical cancer diagnostics industry?
Major companies operating in the cervical cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Zilico Ltd., Guided Therapeutics Inc., Thermo Fisher Scientific Inc., Carl Zeiss AG, OncoHealth Corporation, Arbor Vita Corporation, Micromedic Technologies Ltd., Trovagene Inc., Roche Diagnostics, Nucleix Ltd., BGI Genomics Co. Ltd., Cepheid, Exact Sciences Corporation, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., PerkinElmer Inc., Sysmex Corporation, Veracyte Inc., Zymo Research Corporation

Which regions are leading the growth of the cervical cancer diagnostics market globally?
North America was the largest region in the cervical cancer diagnostics market in 2023 Asia-Pacific was the second largest region in the cervical cancer diagnostics market. The regions covered in the cervical cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Can Companies Use The Cervical Cancer Diagnostics Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
Cervical Cancer Diagnostics Market Report 2025

Need Customized Data On Cervical Cancer Diagnostics Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
Cervical Cancer Diagnostics Market Report 2025

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info


Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Generative Artificial Intelligence (AI) in Logistics Market Report 2025 – Strategic Data for Growth and Expansion

Image
 Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. What is the anticipated market size of the generative artificial intelligence (ai) in logistics industry over the next few years? The generative artificial intelligence (AI) in logistics market size has grown exponentially in recent years. It will grow from $0.6 $ billion in 2024 to $0.8 $ billion in 2025 at a compound annual growth rate (CAGR) of 32.7%. The growth in the historic period can be attributed to increasing demand for real-time data analysis, growth in e-commerce, expansion of global supply chains, increasing industrial infrastructure, and rise of automation in warehouse management. The generative artificial intelligence (AI) in logistics market size is expected to see exponential growth in the next few years. It will grow to $2.46 $ billion in 2029 at a compound annual growth rate (CAGR) of 32.4%. The growth in the forecast period can be ...
Read more

Expand Smarter in the Oncology Devices Market – With This 2025–2034 Forecast Report

Image
Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. How has the oncology devices market size changed in recent years, and what is the outlook ahead? The oncology devices market size has grown rapidly in recent years. It will grow from $150.3 billion in 2024 to $178.95 billion in 2025 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to rising prevalence of cancer, growing aging population, increasing demand for personalized cancer treatments, genomic profiling. The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $346.48 billion in 2029 at a compound annual growth rate (CAGR) of 18.0%. The growth in the forecast period can be attributed to minimally invasive surgical techniques, biodegradable implants, global expansion of healthcare, value-based care models, digital health integration. Major trends in the ...
Read more

Multifamily Housing Green Buildings Market Report 2025 – For Visionary Product and Strategy Executives

Image
Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. What is the projected market size of the multifamily housing green buildings industry, and what is its expected CAGR? The multifamily housing green buildings market size has grown rapidly in recent years. It will grow from $165.26 billion in 2024 to $197.34 billion in 2025 at a compound annual growth rate (CAGR) of 19.4%. The growth in the historic period can be attributed to environmental awareness, cost savings, tenant demand, building certifications. The multifamily housing green buildings market size is expected to see exponential growth in the next few years. It will grow to $414.67 billion in 2029 at a compound annual growth rate (CAGR) of 20.4%. The growth in the forecast period can be attributed to sustainability and climate change, smart building technologies, net zero buildings, digital technologies. Major trends in the forecast period include re...
Read more